Regulation of cytochrome p450 by inflammatory mediators: why and how?

Drug Metab Dispos. 2001 Mar;29(3):207-12.

Abstract

Expression and activities of cytochrome P450 enzymes are down-regulated in the liver during the host response to inflammation or infection, leading to alterations in drug clearance and toxin activation. This review focuses on recent studies on the mechanisms of this down-regulation, as well as the cytokines and cell types involved. Possible reasons for cytochrome P450 down-regulation are discussed.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Arachidonic Acid / metabolism
  • Cytochrome P-450 Enzyme System / metabolism*
  • Cytokines / pharmacology*
  • Down-Regulation / drug effects
  • Homeostasis / physiology
  • Humans
  • Inflammation / metabolism
  • Liver / drug effects
  • Liver / enzymology
  • Liver / metabolism
  • Nitric Oxide / metabolism
  • Oxidative Stress
  • Pharmaceutical Preparations / blood
  • Pharmaceutical Preparations / metabolism
  • Reactive Oxygen Species / metabolism
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Transcription Factors / metabolism

Substances

  • Cytokines
  • Pharmaceutical Preparations
  • Reactive Oxygen Species
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • Arachidonic Acid
  • Nitric Oxide
  • Cytochrome P-450 Enzyme System